Clinical Trials Browser

Completed × Interventional × Arthritis, Juvenile × Clear all

Arthritis, Juvenile, Uveitis

NCT02334748 2020-05-19

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Rheumatoid Arthritis, Systemic Juvenile, Bronchiolitis Obliterans Syndrome, Arthritis, Juvenile, Arthralgia, Mevalonate Kinase Deficiency, Cryopyrin-Associated Periodic Syndromes

NCT03780959 2019-08-02

Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

Phase 2/3 Completed

69 enrolled 11 charts

Arthritis, Juvenile

NCT00964210 2011-04-15

HPV

Phase 3 Completed

240 enrolled

GynecologicLymphoidOther hematologic neoplasm

Arthritis, Juvenile, Uterine Cervical Neoplasms, Inflammatory Bowel Diseases, Renal Insufficiency, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00001862 2008-03-04

TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis

Phase 2 Completed

15 enrolled

Arthritis, Juvenile, Inflammation, Uveitis

Clinical Trials

ADJUVITE

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

HPV

TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis